Zenith Drugs

What Zenith Drugs does

Zenith Drugs Limited is an Indore, India-based pharmaceutical manufacturer founded in 2000 by the late Shri Ramniklal Soni. The company operates a single manufacturing facility in Indore producing over 250 molecules across approximately 780 stock-keeping units (SKUs), with dedicated units for capsules, tablets, dry powders, and topical formulations including ointments, creams, gels, liquid orals, and solutions. Its R&D efforts span therapeutic areas including allergology, infections, genetics, endocrinology, and microbiology, supporting a continuous pipeline of branded generic products such as the Zenilyte line (e.g., Azitherx-500, Biocine-500, Clobetol-Gm, Dr-maa pain-free gel, Zenith ORS).

The company's commercial model is built on four distinct go-to-market channels: a domestic direct-marketing team covering 18+ Indian states (with Madhya Pradesh accounting for 24% of earnings), institutional sales for government and public-health tenders, third-party manufacturing arrangements, and a dedicated export division targeting West Africa, East Africa, Southeast Asia, and Latin America. It is listed on the NSE under the ticker ZENITHDRUG and has published IPO-related documentation on its investor relations page.

Financially, Zenith operates with 101-250 employees, generates undisclosed revenue, and recently executed a ₹6.99 crore preferential allotment of warrants to promoters (announced June 2026) to lift promoter holding to 67.18%. Pricing, customer-level revenue, and profitability are not publicly disclosed. The company differentiates on formulation breadth, multi-channel reach, and 25 years of operating history rather than on proprietary technology or AI capabilities.

Name

Zenith Drugs

Legal name

Zenith Drugs Limited

Website

https://zenithdrugs.com

Company type

Public

Founded year

2000

Operating status

Operating

Headcount range

101–250 employees

Short description

Zenith Drugs Limited is an Indore-based Indian generic pharmaceutical manufacturer producing 250+ molecules and ~780 SKUs across capsules, tablets, topicals, and liquid orals, selling through domestic, institutional, third-party, and export channels spanning 18+ Indian states and targeted markets in Africa, Southeast Asia, and Latin America.

Ownership category

akta.pro rank

Product category

Generic Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

akta.pro secondary industries

Generic Hospital & Institutional Products (HLAIABAL), Generic ANDA/Regulatory Affairs & Submissions (HLAIABAJ)

Keywords

• Generic pharmaceuticals
• Pharmaceutical manufacturing
• Oral formulations
• Capsules tablets
• Government healthcare supply

Headquarters

HQ city

Indore

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Distribution channels4 records

Marketing channels2 records

Core offering

Zenith Drugs manufactures and distributes generic pharmaceutical formulations including oral medicines (ORS powder), Capsules, Tablets, Dry Powders, and topical formulations (Ointments, Creams, Gels, Liquid Oral, Solutions). The Indore-based facility produces over 250 molecules and 780 SKUs across multiple therapeutic areas, supplying both domestic Indian markets (18+ states) and international markets in West/East Africa, Southeast Asia, and Latin America.

Differentiator

Problem solved

Functional benefit

Brands

• Zenilyte: Product division showcasing pharmaceutical formulations including Azitherx-500, Biocine-500, Clobetol-Gm, Dr-maa pain-free gel, K-cet, Metrozen-200, Poviz Plus, Pridezen-5, Rescuff DX, Zenith ORS, and Zoomol-plus.

Products and services

• Zenith Division

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Caplin Point Laboratories: India-listed small/mid-cap generic pharma manufacturer with a heavily Africa-focused export franchise. Highly comparable business model: multi-dosage-form generic manufacturing (including tablets, capsules, topicals) sold across West/East Africa, Latin America, and Asia — overlapping directly with Zenith's stated export strategy.
• Lincoln Pharmaceuticals: India-listed (NSE/BSE) small-cap generic pharma manufacturer based in Gujarat producing tablets, capsules, ointments, syrups, and injectives for domestic and emerging markets. Closely comparable in product breadth, scale, public listing status, and emerging-market export orientation.
• Bajaj Healthcare: India-listed (NSE: BAJAJHCARE) small/mid-cap manufacturer of APIs, intermediates, and finished generic formulations. Comparable on small-cap listed generic manufacturing model with multi-product portfolio and active in regulated and emerging markets.
• Wanbury: India-listed small/mid-cap pharma manufacturer with API and formulations operations across multiple therapeutic categories. Comparable as a small-cap listed Indian generic pharma with diversification across dosage forms, though with some backward-integration into APIs.
• Hester Biosciences: India-listed (NSE/BSE) small/mid-cap manufacturer of veterinary and human health biologicals and formulations. Comparable in scale, listing status, and emerging-market export orientation; differs in therapeutics focus.
• SMS Pharmaceuticals: India-listed small/mid-cap manufacturer specializing in APIs and intermediates with formulation extensions. Comparable small-cap listed Indian pharma with multi-category presence and emerging-market exposure.
• Vivimed Labs: India-listed generic pharma and specialty chemicals company with finished formulations and API operations. Comparable size and operating model with diversified formulations across dosage forms and geographies.
• TTK Healthcare: India-listed pharma, consumer health, and medical devices company with a formulations manufacturing division. Comparable as a domestically anchored, multi-category India-listed pharma manufacturer with diversified sales channels.

Broad incumbents

• Ajanta Pharma: Larger India-listed generic pharma manufacturer with significant branded-generic presence in India, Africa, and Asia. Comparable business model (multi-dosage-form generic manufacturing, Africa-led export franchise), but operates at materially larger scale than Zenith.
• Sequent Scientific: India-listed animal and human health API/formulations manufacturer. Comparable as a diversified small/mid-cap Indian pharma with multiple dosage forms and export reach, though predominantly animal health.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zenith Drugs